Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remedee Labs has developed a non-invasive, wearable device using millimeter wave neuromodulation to stimulate endorphin production, providing clinically validated relief from chronic pain. The company’s solutions have received CE certification in Europe for osteoarthritis and fibromyalgia, with positive clinical results showing significant reduction in pain, improved sleep quality, and better overall quality of life. Their device is the first CE-certified medical device in Europe specifically indicated for fibromyalgia. The solution has also received FDA Breakthrough Device designation for fibromyalgia management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Remedee Labs.